Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II neoadjuvant high-dose ifosfamide plus concurrent radiotherapy in high-risk localized soft tissue sarcoma
2007-005755-42Phase 2Active
- Sponsor
- Spanish Group for Research on Sarcoma
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ifosfamide in soft tissue sarcoma (STS), sponsored by Spanish Group for Research on Sarcoma. Primary endpoints: Radiologic response after neoadjuvant treatment, Pathologic response in the surgical specimen and 3 more. Started Nov 2007; status: active.
02
Drugs
ifosfamide
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on 2007-005755-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005755-42.